Effective anti-BCMA retreatment in multiple myeloma

被引:33
作者
Gazeau, Nicolas [1 ]
Beauvais, David [1 ]
Yakoub-Agha, Ibrahim [1 ,2 ]
Mitra, Suman [3 ,4 ]
Campbell, Timothy B. [5 ]
Facon, Thierry [1 ]
Manier, Salomon [1 ,3 ,4 ]
机构
[1] Lille Univ, Dept Hematol, CHU Lille, Lille, France
[2] Lille Univ, INSERM, Infinite, U1286, Lille, France
[3] Lille Univ, Canther, INSERM, UMR S1277, Lille, France
[4] Lille Univ, CNRS, UMR9020, Lille, France
[5] Bristol Myers Squibb, Princeton, NJ USA
关键词
BAFF; APRIL;
D O I
10.1182/bloodadvances.2021004176
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The recent emergence of anti-B-cell maturation antigen (BCMA) therapies holds great promise in multiple myeloma (MM). These include chimeric antigen receptor (CAR) T cells, bispecific antibodies, and antibody-drug conjugates. Their development in clinical trials and further approval are changing the strategy for treating MM. Considering that a cure has not been reached, a central question in the coming years will be the possibility of using these therapies sequentially. Here, we report 2 cases of the serial use of anti-BCMA therapies with parallel monitoring of BCMA expression and anti-CAR antibodies. We further discuss recent data from clinical studies that have informed us about the different mechanisms of resistance to anti-BCMA therapies, including antigen escape, BCMA shedding, anti-drug antibodies, T-cell exhaustion, and the emergence of an immunosup-pressive microenvironment. This knowledge will be essential to help guide the strategy of serial treatments with anti-BCMA therapies.
引用
收藏
页码:3016 / 3020
页数:5
相关论文
共 25 条
[1]   A Real-Time Quantitative PCR Targeting the Viral Vector for the Monitoring of Patients Treated with Axicabtagene Ciloleucel [J].
Baras, Agathe ;
Bocket, Laurence ;
Beauvais, David ;
Hallaert, Christophe ;
Varlet, Pauline ;
Yakoub-Agha, Ibrahim ;
Hober, Didier ;
Alidjinou, Enagnon Kazali .
JOURNAL OF MOLECULAR DIAGNOSTICS, 2021, 23 (04) :447-454
[2]   Updated Results from an Ongoing Phase 1 Clinical Study of bb21217 Anti-Bcma CAR T Cell Therapy [J].
Berdeja, Jesus G. ;
Alsina, Melissa ;
Shah, Nina D. ;
Siegel, David S. ;
Jagannath, Sundar ;
Madduri, Deepu ;
Kaufman, Jonathan L. ;
Munshi, Nikhil C. ;
Rosenblatt, Jacalyn ;
Jasielec, Jagoda K. ;
Lin, Yi ;
Turka, Ashley ;
Lam, Lyh Ping ;
Massaro, Monica ;
Campbell, Timothy B. ;
Hege, Kristen ;
Petrocca, Fabio ;
Raje, Noopur S. .
BLOOD, 2019, 134
[3]   BAFF, APRIL and their receptors: Structure, function and signaling [J].
Bossen, Claudia ;
Schneider, Pascal .
SEMINARS IN IMMUNOLOGY, 2006, 18 (05) :263-275
[4]   Serum B-cell maturation antigen (BCMA) reduces binding of anti-BCMA antibody to multiple myeloma cells [J].
Chen, Haiming ;
Li, Mingjie ;
Xu, Ning ;
Ng, Nicole ;
Sanchez, Eric ;
Soof, Camilia M. ;
Patil, Saurabh ;
Udd, Kyle ;
Bujarski, Sean ;
Cao, Jasmin ;
Hekmati, Tara ;
Ghermezi, Matthew ;
Zhou, Mizi ;
Wang, Emily Y. ;
Tanenbaum, Edward J. ;
Zahab, Brian ;
Schlossberg, Remy ;
Yashar, Moryel A. ;
Wang, Cathy S. ;
Tang, George Y. ;
Spektor, Tanya M. ;
Berenson, James R. .
LEUKEMIA RESEARCH, 2019, 81 :62-66
[5]   Serial treatment of relapsed/refractory multiple myeloma with different BCMA-targeting therapies [J].
Cohen, Adam D. ;
Garfall, Alfred L. ;
Dogan, Ahmet ;
Lacey, Simon F. ;
Martin, Chris ;
Lendvai, Nikoletta ;
Vogl, Dan T. ;
Spear, Matthew ;
Lesokhin, Alexander M. .
BLOOD ADVANCES, 2019, 3 (16) :2487-2490
[6]   B cell maturation antigen-specific CAR T cells are clinically active in multiple myeloma [J].
Cohen, Adam D. ;
Garfall, Alfred L. ;
Stadtmauer, Edward A. ;
Melenhorst, J. Joseph ;
Lacey, Simon F. ;
Lancaster, Eric ;
Vogl, Dan T. ;
Weiss, Brendan M. ;
Dengel, Karen ;
Nelson, Annemarie ;
Plesa, Gabriela ;
Chen, Fang ;
Davis, Megan M. ;
Hwang, Wei-Ting ;
Young, Regina M. ;
Brogdon, Jennifer L. ;
Isaacs, Randi ;
Pruteanu-Malinici, Iulian ;
Siegel, Don L. ;
Levine, Bruce L. ;
June, Carl H. ;
Milone, Michael C. .
JOURNAL OF CLINICAL INVESTIGATION, 2019, 129 (06) :2210-2221
[7]   First Clinical Study of the B-Cell Maturation Antigen (BCMA) 2+1 T Cell Engager (TCE) CC-93269 in Patients (Pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Interim Results of a Phase 1 Multicenter Trial [J].
Costa, Luciano J. ;
Wong, Sandy W. ;
Bermudez, Arancha ;
de la Rubia, Javier ;
Mateos, Maria-Victoria ;
Ocio, Enrique M. ;
Rodriguez-Otero, Paula ;
San-Miguel, Jesus ;
Li, Shaoyi ;
Sarmiento, Rafael ;
Lardelli, Pilar ;
Gaudy, Allison ;
Boss, Isaac ;
Kelly, Lisa M. ;
Burgess, Michael R. ;
Hege, Kristen ;
Bensinger, William I. .
BLOOD, 2019, 134
[8]   Homozygous BCMA gene deletion in response to anti-BCMA CAR T cells in a patient with multiple myeloma [J].
Da Via, Matteo C. ;
Dietrich, Oliver ;
Truger, Marietta ;
Arampatzi, Panagiota ;
Duell, Johannes ;
Heidemeier, Anke ;
Zhou, Xiang ;
Danhof, Sophia ;
Kraus, Sabrina ;
Chatterjee, Manik ;
Meggendorfer, Manja ;
Twardziok, Sven ;
Goebeler, Maria-Elisabeth ;
Topp, Max S. ;
Hudecek, Michael ;
Prommersberger, Sabrina ;
Hege, Kristen ;
Kaiser, Shari ;
Fuhr, Viktoria ;
Weinhold, Niels ;
Rosenwald, Andreas ;
Erhard, Florian ;
Haferlach, Claudia ;
Einsele, Hermann ;
Kortuem, K. Martin ;
Saliba, Antoine-Emmanuel ;
Rasche, Leo .
NATURE MEDICINE, 2021, 27 (04) :616-619
[9]   γ-secretase directly sheds the survival receptor BCMA from plasma cells [J].
Laurent, Sarah A. ;
Hoffmann, Franziska S. ;
Kuhn, Peer-Hendrik ;
Cheng, Qingyu ;
Chu, Yuanyuan ;
Schmidt-Supprian, Marc ;
Hauck, Stefanie M. ;
Schuh, Elisabeth ;
Krumbholz, Markus ;
Ruebsamen, Heike ;
Wanngren, Johanna ;
Khademi, Mohsen ;
Olsson, Tomas ;
Alexander, Tobias ;
Hiepe, Falk ;
Pfister, Hans-Walter ;
Weber, Frank ;
Jenne, Dieter ;
Wekerle, Hartmut ;
Hohlfeld, Reinhard ;
Lichtenthaler, Stefan F. ;
Meinl, Edgar .
NATURE COMMUNICATIONS, 2015, 6
[10]   Cite-Seq Profiling of T Cells in Multiple Myeloma Patients Undergoing BCMA Targeting CAR-T or Bites Immunotherapy [J].
Leblay, Noemie ;
Maity, Ranjan ;
Barakat, Elie ;
McCulloch, Sylvia ;
Duggan, Peter ;
Jimenez-Zepeda, Victor ;
Bahlis, Nizar J. ;
Neri, Paola .
BLOOD, 2020, 136